...
首页> 外文期刊>Psychoneuroendocrinology: An International Journal >MicroRNA-155 deletion reduces anxiety- and depressive-like behaviors in mice
【24h】

MicroRNA-155 deletion reduces anxiety- and depressive-like behaviors in mice

机译:MicroRNA-155缺失可减少小鼠的焦虑和抑郁样行为

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Depressive disorders have complex and multi-faceted underlying mechanisms, rendering these disorders difficult to treat consistently and effectively. One under-explored therapeutic strategy for alleviating mood disorders is the targeting of microRNAs (miRs). miRs are small non-coding RNAs that cause sequestration/degradation of specific mRNAs, thereby preventing protein translation and downstream functions. miR-155 has validated and predicted neurotrophic factor and inflammatory mRNA targets, which led to our hypothesis that miR-155 deletion would modulate affective behaviors. To evaluate anxiety-like behavior, wildtype (wt) and miR-155 knockout (ko) mice (littermates; both male and female) were assessed in the open field and on an elevated plus maze. In both tests, miR-155 ko mice spent more time in open areas, suggesting they had reduced anxiety-like behavior. Depressive-like behaviors were assessed using the forced swim test. Compared to wt mice, miR-155 ko mice exhibited reduced float duration and increased latency to float. Further, although all mice exhibited a strong preference for a sucrose solution over water, this preference was enhanced in miR-155 ko mice. miR-155 ko mice had no deficiencies in learning and memory (Barnes maze) or social preferenceovelty suggesting that changes in mood were specific. Finally, compared to wt hippocampi, miR-155 ko hippocampi had a reduced inflammatory signature (e.g., decreased IL-6, TNF-a) and female miR-155 ko mice increased ciliary neurotrophic factor expression. Together, these data highlight the importance of studying microRNAs in the context of anxiety and depression and identify miR-155 as a novel potential therapeutic target for improving mood disorders. (C) 2015 Elsevier Ltd. All rights reserved.
机译:抑郁症具有复杂且多方面的潜在机制,使得这些疾病难以持续有效地治疗。尚未开发的缓解情绪障碍的治疗策略是靶向microRNA(miR)。 miR是小的非编码RNA,会导致特定mRNA的螯合/降解,从而阻止蛋白质翻译和下游功能。 miR-155已经验证并预测了神经营养因子和炎症性mRNA靶标,这导致我们的假设是miR-155缺失会调节情感行为。为了评估类似焦虑的行为,在旷野和高架迷宫中评估了野生型(wt)和miR-155敲除(ko)小鼠(同窝仔;雄性和雌性)。在这两项测试中,miR-155 ko小鼠在空旷地区花费了更多时间,表明它们的焦虑样行为减少了。使用强迫游泳测试评估抑郁症样行为。与wt小鼠相比,miR-155 ko小鼠的漂浮时间减少,漂浮潜伏期延长。此外,尽管所有小鼠都比水表现出对蔗糖溶液的强烈偏好,但在miR-155 ko小鼠中这种偏好得到了增强。 miR-155 ko小鼠在学习和记忆方面(Barnes迷宫)或社交偏好/新奇没有缺陷,表明情绪变化是特定的。最后,与野生型海马相比,miR-155 ko海马的炎症反应减少(例如,IL-6,TNF-α降低),而雌性miR-155 ko海鼠的睫状神经营养因子表达增加。总之,这些数据突出了在焦虑和抑郁的背景下研究microRNA的重要性,并将miR-155鉴定为改善情绪障碍的新型潜在治疗靶标。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号